Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications. Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures.
View Top Employees from Anavo Therapeutics BVWebsite | http://www.anavotx.com |
Employees | 25 (7 on RocketReach) |
Address | J.H. Oortweg 19, Leiden, South Holland 2333 CH, NL |
Industry | Biotechnology Research |
Looking for a particular Anavo Therapeutics BV employee's phone or email?
Shaun McNulty is the Chief Scientific Officer of Anavo Therapeutics BV.
7 people are employed at Anavo Therapeutics BV.
Anavo Therapeutics BV is based in Leiden, South Holland.